BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2310279)

  • 1. Hypoalbuminemia in patients with multiple myeloma.
    Chen YH; Magalhaes MC
    Arch Intern Med; 1990 Mar; 150(3):605-10. PubMed ID: 2310279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma.
    Kim JE; Yoo C; Lee DH; Kim SW; Lee JS; Suh C
    Ann Hematol; 2010 Apr; 89(4):391-7. PubMed ID: 19844712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homogeneous immunoglobulins in Ghanaians living in Accra, Ghana.
    Oyeyinka GO; Ofei V; Maddy SQ; Duah OA; Akafo SK; Aquaye JK; Dosoo DK
    Afr J Med Med Sci; 2004 Dec; 33(4):311-6. PubMed ID: 15977437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring myelomatosis.
    Hobbs JR
    Arch Intern Med; 1975 Jan; 135(1):125-30. PubMed ID: 1111461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical classification of plasma cell myeloma.
    Conklin R; Alexanian R
    Arch Intern Med; 1975 Jan; 135(1):139-43. PubMed ID: 1111462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma. 2. A report on sixty-seven cases.
    Hill RS; Wilson JD
    N Z Med J; 1968 Feb; 67(428):194-203. PubMed ID: 5238829
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognostic factors in IgG and micromolecular multiple myeloma. Retrospective analysis of 50 consecutive cases].
    Pasqualetti P; Casale R; Colantonio D; Festuccia V; Di Lauro G; Natali G
    Minerva Med; 1987 May; 78(9):603-8. PubMed ID: 3587727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors in multiple myeloma].
    Pick AI; Tamir R; Vana D; Duczyminer-Kahana M; Weiss H; Lurie H; Dawidowich J; Meyerson E; Gelernter I
    Harefuah; 1990 Apr; 118(8):437-42. PubMed ID: 2358224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple myeloma in two brothers. Immunoglobulin levels among their relatives.
    Wiedermann D; Urban P; Wiedermann B; Cídl K
    Neoplasma; 1976; 23(2):197-207. PubMed ID: 934388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Idiopathic" Bence Jones proteinuria: long-term follow-up in seven patients.
    Kyle RA; Greipp PR
    N Engl J Med; 1982 Mar; 306(10):564-7. PubMed ID: 7057813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum albumin level before initiating haemodialysis and angiographic severity of coronary atherosclerosis in end-stage renal disease patients.
    Joki N; Hase H; Tanaka Y; Takahashi Y; Saijyo T; Ishikawa H; Inishi Y; Imamura Y; Hara H; Tsunoda T; Nakamura M
    Nephrol Dial Transplant; 2006 Jun; 21(6):1633-9. PubMed ID: 16488920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric (presumed tetrameric) lambda Bence Jones proteinemia without proteinuria in a patient with multiple myeloma.
    Hom BL
    Am J Clin Pathol; 1984 Nov; 82(5):627-9. PubMed ID: 6437210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of IgG-kappa type multiple myeloma complicated by Fanconi syndrome].
    Sakaue S; Nakata K; Nagata H; Yamaguchi J
    Rinsho Ketsueki; 1994 Aug; 35(8):786-91. PubMed ID: 7933567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-pathological studies of tumor-forming type of multiple myeloma].
    Fujii H; Seki S
    Gan No Rinsho; 1983 Jul; 29(8):903-10. PubMed ID: 6887523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytoma, cancer and other associations of monoclonal gammopathy: a review of 224 cases.
    Colls BM; Lorier MA
    N Z Med J; 1975 Oct; 82(549):221-6. PubMed ID: 1059967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal disease in myeloma. Role of the tumor cell mass (author's transl)].
    San Miguel J; Batlle J; Alberca I; Moraleda JM; López Borrasca A
    Med Clin (Barc); 1981 Apr; 76(8):347-9. PubMed ID: 7253752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical abnormalities in multiple myeloma.
    Choo-Kang E; Campbell M
    West Indian Med J; 1991 Dec; 40(4):170-2. PubMed ID: 1785196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function.
    Nozza A; Siracusano L; Armando S
    Clin Ther; 2006 Jun; 28(6):953-9. PubMed ID: 16860177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple myeloma of IgG-lambda type associated with asymptomatic primary biliary cirrhosis].
    Fujii H; Yashige H
    Rinsho Ketsueki; 1989 Oct; 30(10):1886-91. PubMed ID: 2512398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in multiple myeloma: parametric analysis in each abnormal protein type.
    Oguma S; Takatsuki K; Uchino H
    Gan; 1981 Jun; 72(3):354-62. PubMed ID: 7319195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.